Root Financial Partners
FMED icon

Root Financial Partners’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Root Financial Partners’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.8K Buy
+1,291
New +$39.4K ﹤0.01% 1171

Other funds holding FMED

Spire Wealth Management
Spire Wealth Management Mclean, Virginia $3.27B AUM 30.11% 1-Year Est. Return
Rydar Equities
Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Central Pacific Bank - Trust Division
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
Glass Jacobson Investment Advisors
Glass Jacobson Investment Advisors Owings Mills, Maryland $326M AUM 13.52% 1-Year Est. Return

Root Financial Partners's FMED Position: Q3 2026 in Review

Root Financial Partners opened a new position in Fidelity Disruptive Medicine ETF (FMED) in Q3 2026: 1,291 shares worth $41.8K. The stake represents ﹤0.01% of the portfolio and ranks #1171 among its holdings.

6 funds tracked by Wall St. Rank hold FMED as of Q3 2026.

  • Root Financial Partners held 1,291 shares of Fidelity Disruptive Medicine ETF worth $41.8K as of Q3 2026.
  • Fidelity Disruptive Medicine ETF was a new Root Financial Partners position in Q3 2026.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1171 holding.
  • 6 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.